rosiglitazone has been researched along with Colitis Gravis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 8 (80.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Da Silva, S; Keita, ÅV; Mattson, JP; Mohlin, S; Påhlman, I; Påhlman, S; Söderholm, JD; Theodorou, V | 1 |
| Aberra, FN; Chuai, S; Ellenberg, JH; Lewis, JD; Lichtenstein, GR; Nessel, L | 1 |
| Brynskov, J; Pedersen, G | 1 |
| Liang, HL; Ouyang, Q | 2 |
| Fernández, PL | 1 |
| de la Lastra, CA; Martín, AR; Sánchez-Hidalgo, M; Villegas, I | 1 |
| Chuai, S; Deren, JJ; Ellenberg, JH; Hanauer, SB; Katz, JA; Lashner, B; Lewis, JD; Lichtenstein, GR; Nessel, L; Present, DH; Sands, BE; Wu, GD | 1 |
| Blumberg, RS; Nakajima, A; Wada, K | 1 |
| Demissie, EJ; Deren, JJ; Fogt, F; Furth, EE; Hurd, LB; Judge, TA; Keilbaugh, SA; Lazar, MA; Lewis, JD; Lichtenstein, GR; Stein, RB; Su, CG; Wu, GD | 1 |
5 trial(s) available for rosiglitazone and Colitis Gravis
| Article | Year |
|---|---|
Use of the noninvasive components of the Mayo score to assess clinical response in ulcerative colitis.
Topics: Colitis, Ulcerative; Fibrinolytic Agents; Humans; Hypoglycemic Agents; Placebos; Remission Induction; ROC Curve; Rosiglitazone; Sensitivity and Specificity; Thiazolidinediones; Treatment Outcome | 2008 |
Topical rosiglitazone treatment improves ulcerative colitis by restoring peroxisome proliferator-activated receptor-gamma activity.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Biopsy; Blotting, Western; Colitis, Ulcerative; Colonoscopy; Enema; Female; Humans; Hypoglycemic Agents; Male; Membrane Proteins; Mesalamine; Middle Aged; Peptides; Perilipin-2; PPAR gamma; Reverse Transcriptase Polymerase Chain Reaction; Rosiglitazone; Statistics, Nonparametric; Thiazolidinediones | 2010 |
[A clinical trial of rosiglitazone and 5-aminosalicylate combination for ulcerative colitis].
Topics: Adolescent; Adult; Aminosalicylic Acids; Anti-Inflammatory Agents; Colitis, Ulcerative; Colon; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; NF-kappa B; PPAR gamma; Rosiglitazone; Thiazolidinediones | 2006 |
A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Drug Therapy, Combination; Female; Humans; Hypoglycemic Agents; Male; Mesalamine; Middle Aged; Rosiglitazone; Thiazolidinediones; Treatment Outcome | 2008 |
Rosiglitazone for active ulcerative colitis: a randomized placebo-controlled trial.
Topics: Administration, Oral; Adult; Anti-Inflammatory Agents; Colitis, Ulcerative; Colonoscopy; Double-Blind Method; Drug Administration Schedule; Female; Gastrointestinal Agents; Humans; Male; Middle Aged; Patient Selection; Quality of Life; Rosiglitazone; Severity of Illness Index; Sigmoidoscopy; Thiazolidinediones; Time Factors; Treatment Outcome; United States | 2008 |
5 other study(ies) available for rosiglitazone and Colitis Gravis
| Article | Year |
|---|---|
A Novel Topical PPARγ Agonist Induces PPARγ Activity in Ulcerative Colitis Mucosa and Prevents and Reverses Inflammation in Induced Colitis Models.
Topics: Adult; Aged; Animals; Colitis; Colitis, Ulcerative; Colon; Cytokines; Dextran Sulfate; Female; Humans; Intestinal Mucosa; Male; Mice, Inbred BALB C; Middle Aged; Perilipin-2; Peroxidase; PPAR gamma; Rosiglitazone; Trinitrobenzenesulfonic Acid | 2018 |
[Stress and inflammatory bowell disease (I.B.D). Therapeutic strategies].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Bacterial Translocation; Colitis, Ulcerative; Disease Models, Animal; Humans; Immobilization; Immunoglobulin A; Inflammatory Bowel Diseases; PPAR gamma; Prostaglandin D2; Prostaglandins; Rats; Rosiglitazone; Stress, Psychological; Thiazolidinediones; Time Factors | 2006 |
Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Topics: Acute Disease; Animals; Apoptosis; Blotting, Western; Colitis, Ulcerative; Cyclooxygenase 1; Cyclooxygenase 2; Cytokines; Dinoprostone; Hypoglycemic Agents; Immunoblotting; Inflammation; Male; Mitogen-Activated Protein Kinases; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peroxidase; PPAR gamma; Rats; Rats, Wistar; Rosiglitazone; Signal Transduction; Thiazolidinediones; Transcription Factor RelA; Trinitrobenzenesulfonic Acid; Tumor Necrosis Factor-alpha | 2007 |
PPARgamma and inflammatory bowel disease: a new therapeutic target for ulcerative colitis and Crohn's disease.
Topics: Animals; Anti-Inflammatory Agents; Chromans; Colitis, Ulcerative; Crohn Disease; Disease Models, Animal; Inflammation; Intestines; Ligands; Mice; Receptors, Cytoplasmic and Nuclear; Rosiglitazone; Thiazoles; Thiazolidinediones; Transcription Factors; Troglitazone | 2001 |
An open-label trial of the PPAR-gamma ligand rosiglitazone for active ulcerative colitis.
Topics: Adult; Aged; Colitis, Ulcerative; Colonoscopy; Female; Humans; Ligands; Male; Middle Aged; Prospective Studies; Receptors, Cytoplasmic and Nuclear; Remission Induction; Rosiglitazone; Severity of Illness Index; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |